UCP2 and Huntington disease: Consistently, we observed a decrease in UCP2 mRNA levels in HD-iPSC (67%), suggesting that UCP2 can assume an important role in endogenous ROS management, prompting HD-iPSC susceptibility to mitochondrial dysfunction associated with increased ROS production.